The Affinity Column: How Biotechnology Can Improve Environmental Health and Sustainability
Dr. Melinda Verdone discusses current sustainable biotechnologies, including plastic alternatives, biomaterials, and biofuels.
Experience UW Applied Biotechnology
The Affinity Column: The Not-So-Distant Future of Biotechnology
UW Applied Biotechnology Program Manager, Dr. Melinda Verdone, covers what to expect in the near future within biotechnology.
UW Applied Biotechnology Degree Guide
Download a four-page overview of the online UW Master of Science in Applied Biotechnology, including information on courses, careers, and tuition.
The Affinity Column: Biotechnology Breakthroughs Honored in 2020
UW Applied Biotechnology Program Manager, Dr. Melinda Verdone, features the key scientists behind the biotech breakthroughs acknowledged in 2020.
UW Applied Biotechnology Course Wins ADEIL Distinguished Course Award
ABT 705: Ethics, Safety, and Regulatory Environments in Biotechnology won a Distinguished Course award from ADEIL.
The Affinity Column: What We Know About COVID-19 mRNA Vaccines
Dr. Melinda Verdone discusses COVID-19 mRNA vaccines, their distribution to the public, and what the next steps in fighting COVID-19 will be.
The Affinity Column: Navigating Science Education Challenges
In this month's Affinity Column, UW Applied Biotechnology Program Manager Dr. Melinda Verdone focuses on biotechnology education.
The Affinity Column: The Business of Biotechnology – Leadership, Investments, and High School Teachers
In this month’s Affinity Column, UW Applied Biotechnlogy Program Manager Dr. Melinda Verdone focuses on the business side of biotechnology.
The Affinity Column: Emerging Biotechnology Trends in the Food Industry
UW Applied Biotechnology Program Manager Dr. Melinda Verdone highlights three emerging biotechnology developments in the food industry.
The Affinity Column: What We’ve Learned about COVID-19
UW Applied Biotechnology Program Manager, Dr. Melinda Verdone, reviews what we've learned about COVID-19 and the vaccines in development.
The Affinity Column: Diversity, Equity, and Inclusion within Biotechnology
Along with many industries, biotechnology struggles with racial and gender inequalities. This month's column brings to light areas that need to change.
